SRI Biosciences’ Center for Neuroscience and Metabolic Diseases combines world-class basic science with contract research to provide an ideal environment for partnering with clients and advancing research and development programs.

We conduct basic and translational research in the areas of sleep and circadian rhythms, cognition, pain and addiction, obesity, osteoporosis, and type II diabetes using methodologies such as molecular biology, electrophysiology, microdialysis, and behavioral testing.

Our team facilitates the success of discovery programs by investigating the molecular basis of disease, identifying and validating novel therapeutic targets, and conducting in vitro and in vivo efficacy and safety assessments. Our translational research focus has provided critical Proof of Concept (POC) studies to support FDA Investigational New Drug (IND) files for several central nervous system indications.